3 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow Cholinergic Antagonists: new trials by email Literature Review of Cholinergic Antagonists trials Research Report on Cholinergic Antagonists
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children Beta3-Agonists, Adrenergic, Anticholinergic drug, Solifenacin - Voiding Disorders, Overactive Bladder | Phase 1 / Phase 2 | Unknown | Mansoura University | 70 | 2022-02-01 | 2022-02-15 |
| Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers. Darifenacin - Bioequivalency | Phase 1 | Unknown | Center for Clinical Pharmacology Research Bdbeq S.A. | 24 | 2010-12-01 | 2010-10-27 |
| Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers. Darifenacin - Bioequivalency | Phase 1 | Unknown | Center for Clinical Pharmacology Research Bdbeq S.A. | 24 | 2010-11-01 | 2010-10-25 |
Urinary Bladder, Overactive (1)
Center for Clinical Pharmacology Research Bdbeq S.A. (2) · Mansoura University (1)
Uruguay (2)
Francisco E. Estevez-Carrizo, MD (2) · Susana Parrillo, M.D. (2) · Islam Mansour, Mb ChB (1)